NCT05998811View on ClinicalTrials.gov

Insights Into Participating in Studies for Uterine Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Uterine Cancer
Trial Locations (1)

94107

Power Life Sciences, San Francisco

Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT05998811 - Insights Into Participating in Studies for Uterine Cancer | Biotech Hunter | Biotech Hunter